Physician profile
Mara E Schuh
NPI 1720568553
$1,244.27
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,147 · 2022: $56.18 · 2023: $18.57 · 2024: $22.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $586.28 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $129.42 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.66 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.07 | 2021 | |
| Novo Nordisk INC | $58.03 | 2021 | |
| Daiichi Sankyo INC. | $51.09 | 2021-2022 | |
| Glaxosmithkline, LLC. | $47.20 | 2021 | |
| Alnylam Pharmaceuticals INC. | $40.77 | 2021 | |
| Ironwood Pharmaceuticals, INC | $32.76 | 2021 | |
| Agile Therapeutics, INC. | $27.78 | 2021 | |
| Alexion Pharmaceuticals, INC. | $24.27 | 2021 | |
| Tactile Systems Technology INC | $22.65 | 2024 | Entre Plus, Flexitouch Plus |
| Dexcom, INC. | $21.81 | 2021 | |
| Scpharmaceuticals INC. | $18.57 | 2023 | |
| Merck Sharp & Dohme LLC | $16.67 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.91 | 2021 | |
| Pfizer INC. | $13.50 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mara Schuh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.